aTyr Pharma (NASDAQ:LIFE) Upgraded at StockNews.com
StockNews.com upgraded shares of aTyr Pharma (NASDAQ:LIFE – Free Report) from a sell rating to a hold rating in a research report sent to investors on Friday morning. Separately, HC Wainwright restated a buy rating and issued a $35.00 target price on shares of aTyr Pharma in a research report on Thursday, September 21st. Two […]
More Stories
Netflix’s New Drama, Allen Is Arriving! Release Date, Cast, Trailer & More
Good News for fans of Bluey. Ludo Studio has created its first live-action feature film, Allen. Daley Pearson is leading...
How to Build a Cleaning Routine That Helps Reduce Household Dust
Why a Cleaning Routine Matters Household dust has a way of settling everywhere—on floors, countertops, bedding, shelves, and the tops...
The Midterm Fraud Machine: How Corruption, Confusion, and Judicial Abdication Are Stealing America’s 2026 Elections
By Stephen Zogopoulos, USNN World News On November 3, 2026, Americans went to the polls in a midterm election that...
US Economy in Late 2026: Steady Growth, Sticky Inflation, and a Return to Tariff-Based Trade Policy
By Stephen Zogopoulos, USNN World News As of early November 2026, the U.S. economy continues to expand at a moderate...
Major Automakers Side With Trump in Legal Battle Over Eased Fuel Economy Standards
By Kimberly Hayek A major auto industry group has thrown its support behind the Trump administration in a lawsuit brought...
Oil Prices Rise After Reports of Explosions on Iran’s Qeshm Island
By Evgenia Filimianova Oil prices climbed by more than 1.5 percent early on Nov. 3 after reports of explosions on...